News + Filings Transactions
|
RICHMAN ERIC I
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/20/2022 | Gain Therapeutics, Inc. | | Grant | Employee Stock Option (right to buy) | 329.4k | $3.50 | $1.2M | | 09/20/2022 |
| 09/20/2022 | Gain Therapeutics, Inc. | | Grant | Restricted Stock Units | 54.9k | $0.00 | $0 | | 09/20/2022 |
| 09/09/2022 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 37.6k | $0.60 | $22.6k | | 09/09/2022 |
| 05/25/2022 | Gain Therapeutics, Inc. | | Purchase | Common stock | 2.5k | $2.58 | $6.4k | | 05/25/2022 |
| 05/20/2022 | Gain Therapeutics, Inc. | | Purchase | Common Stock | 9.3k | $2.83 | $26.2k | | 05/19/2022 |
| 05/19/2022 | Gain Therapeutics, Inc. | | Purchase | Common stock | 4k | $2.71 | $10.8k | | 05/19/2022 |
| 03/04/2022 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common stock | 1000 | $1.62 | $1.6k | | 03/01/2022 |
| 03/03/2022 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common stock | 1.3k | $1.72 | $2.2k | | 03/01/2022 |
| 03/01/2022 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common stock | 1.6k | $1.58 | $2.5k | | 03/01/2022 |
| 08/19/2021 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 38.1k | $3.36 | $128.1k | | 08/19/2021 |
| 08/16/2021 | Gain Therapeutics, Inc. | | Purchase | Common Stock | 4.9k | $7.87 | $38.7k | | 08/16/2021 |
| 08/16/2021 | Gain Therapeutics, Inc. | | Exercise | Common Stock | 4.9k | $7.87 | $38.7k | | 08/16/2021 |
| 09/09/2020 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 14.6k | $8.80 | $128.8k | | 09/09/2020 |
| 04/30/2020 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common stock | 2.5k | $6.00 | $15k | See footnote | 04/30/2020 |
| 04/30/2020 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common stock | 8.3k | $6.00 | $50k | | 04/30/2020 |
| 02/28/2020 | ADMA BIOLOGICS, INC. | ADMA | Grant | Employee Stock Option (right to buy) | 15k | $2.92 | $43.7k | | 02/28/2020 |
| 02/28/2020 | ADMA BIOLOGICS, INC. | ADMA | Grant | Common Stock | 7.5k | $0.00 | $0 | | 02/28/2020 |
| 07/12/2019 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 227.3k | $5.39 | $1.2M | | 07/12/2019 |
| 07/12/2019 | NeuBase Therapeutics, Inc. | OHRP | Grant | Common stock | 25.2k | $0.00 | $0 | See footnote | 07/12/2019 |
| 03/13/2019 | ADMA BIOLOGICS, INC. | ADMA | Grant | Stock Option (right to buy) | 30k | $3.89 | $116.7k | | 03/13/2019 |
| 06/22/2018 | ADMA BIOLOGICS, INC. | ADMA | Grant | Stock Option (right to buy) | 17.5k | $4.91 | $85.9k | | 06/22/2018 |
| 06/08/2018 | ADMA BIOLOGICS, INC. | ADMA | Purchase | Common Stock | 5.2k | $4.78 | $25k | | 06/08/2018 |
| 11/09/2017 | ADMA BIOLOGICS, INC. | ADMA | Purchase | Common Stock | 25k | $2.15 | $53.8k | | 11/09/2017 |
| 07/13/2017 | ADMA BIOLOGICS, INC. | ADMA | Exercise | Employee Stock Option (right to buy) | 2.8k | $2.68 | $7.5k | | 07/13/2017 |
| 06/06/2017 | ADMA BIOLOGICS, INC. | ADMA | Grant | Stock Option (right to buy) | 78.1k | $3.66 | $286k | | 06/06/2017 |
| 01/28/2016 | ADMA BIOLOGICS, INC. | ADMA | Grant | Options to purchase | 9k | $0.00 | $0 | | 01/28/2016 |
| 08/02/2015 | Altimmune, Inc. | PIP | Grant | Stock options (right to buy) | 20k | $1.69 | $33.8k | | 08/02/2015 |
| 03/13/2015 | ADMA BIOLOGICS, INC. | ADMA | Purchase | Common Stock, $0.0001 par value per share | 2.5k | $7.90 | $19.8k | | 03/13/2015 |
| 03/13/2015 | ADMA BIOLOGICS, INC. | ADMA | Purchase | Common Stock, $0.0001 par value per share | 1000 | $7.82 | $7.8k | | 03/13/2015 |
| 01/30/2015 | ADMA BIOLOGICS, INC. | ADMA | Grant | Options to purchase | 9k | $0.00 | $0 | | 01/30/2015 |
| 12/11/2014 | Altimmune, Inc. | PIP | Grant | Stock options (right to buy) | 271.3k | $1.71 | $464k | | 12/11/2014 |
| 06/19/2014 | ADMA BIOLOGICS, INC. | ADMA | Grant | Options to purchase | 9k | $0.00 | $0 | | 06/19/2014 |
| 01/29/2014 | Altimmune, Inc. | PIP | Grant | Stock Options (right to buy) | 320k | $1.94 | $620.8k | | 01/29/2014 |
|